Some microbial pathogens depend on metalloproteases to cross the blood brain barrier (BBB), and this mechanism may someday be harnessed to deliver drugs to the brain, according to several researchers who spoke at the symposium "This is Your Brain on Microbes," during the 2014 ASM General Meeting in Boston last May. While some metalloproteases are encoded by the pathogens themselves, others are induced in host tissues, the researchers point out.
At least 11 different families of DNA and RNA viruses cause encephalitis, according to Katherine Spindler of the University of Michigan in Ann Arbor. The way that mouse adenovirus-1 (MAV-1) disrupts the BBB differs from several bacterial mechanisms, which instead depend on inflammation, T-cell responses, or endothelial cell apoptosis, she says. The adenovirus acts on tight junction proteins that ordinarily hold endothelial cells together, thereby compromising their function as a barrier and thus allowing viral particles to pass from the bloodstream into brain tissue.
Specifıcally, the virus up-regulates host matrix metalloproteinases (MMPs) that, in turn, digest the tight junction proteins during such infections, according to Spindler. "We have seen increased MMP activity in whole mouse brain homogenates in multiple MAV-1-infected susceptible mouse strains and not in resistant mouse strains," she says. Although the virus infects endothelial cells, cell culture data suggest that astrocytes produce MMPs, she points out.
The fungus Cryptococcus neoformans secretes its own metalloprotease, designated Mpr1, which enables this pathogen to traverse the BBB, according to Mantana Jamklang, who works with Angie Gelli at the University of California, Davis. Mutants of this fungus that are defıcient in Mpr1 are less virulent for mice, and such mutant fungi are found less frequently in the brains of animals that they infect. However, when injected directly into the brains of mice, the mutants survive just as well as do wild-type fungi. Mpr1 appears to enable the fungi to attach to host endothelial cells of the BBB before the fungus can cross into the brain, according to Jamklang.
"We anticipate that our fındings will lead the way to the development of a novel class of antifungal drugs that may prove to be more effıcacious and less toxic than the current limited repertoire of drugs available to patients," Gelli says. "The BBB is a major obstacle preventing therapeutic drugs from getting into the brain, thus one of our research goals is to create a platform technology that will improve the safety and effıcacy of treatments for brain disorders."
Another collaborator of hers, John Uhrig, is linking Mpr1 to silicon nanoparticles, which cannot cross the BBB on their own but may do so when chaperoned by Mpr1. If so, such particles can be loaded with therapeutic compounds for delivery into the brain.
Crosslinking retains the enzymatic
Cryptococcus neoformans cells in lung tissue. These opportunistic pathogens are able to cross the blood-brain barrier using a metalloprotease that disrupts the tight junctions that are normally impassable barrier to cells and large molecules. Soils from widely varied environments, including South and North American semiarid deserts, alpine forests, wetlands, and landscape lawns, contain about 10 6 CFU of bacteria per gram, according to Zhang and Sun. When they bathed such soils with Dand L-amino acids, the soil bacteria responded in one of two distinct ways. Wetland and lawn soils used both types of amino acids simultaneously. However, bacteria from the other types of soils fırst consumed L-amino acids before consuming the D forms.
All the bacteria from different soil types that were being tested "are capable of reverse racemization," Sun says. Moreover, the racemases that the bacteria use when metabolizing several different types of D-amino acids, including D-aspartic acid, D-glutamic acid, and D-leucine, are inducible, he adds. With D-alanine, for example, provided to soil bacteria in excess, "alanine racemases are temporarily freed . . . to serve a detoxifıcation and catabolic function."
This mechanism for detoxifying Damino acids is "potentially important," says Robert A. Lodder of the University of Kentucky in Lexington. Although not all D-amino acids are toxic to humans, some of them cause "tingling and burning sensations" when consumed, symptoms that suggest but by no means prove nerve damage.
In broader terms, these fındings do not fıt neatly with what textbooks say about amino acid racemases and Damino acids, according to Sun. "Because we always grow bacteria in Lamino acids, you only see the L to D conversion," he says. "Our work suggests that this is only half the picture." Outside laboratories, however, soil bacteria are likely exposed to D-amino acids. Instead of this proving harmful, he adds, the exposed bacteria "gain" nutrients that other organisms fınd toxic.
"Even though life on Earth is based on L-amino acids, there is no reason to believe that life based on D-amino acids could not exist on another planet," Sun says. Based on our assessment, native bacteria should always emerge victorious, and any alien organisms eliminated. This is very different from current thinking where people worry about alien organisms attacking us to decimate life on Earth. To me that is unlikely to happen." "Since they do not compete, L-and D-life forms could exist together, and I wonder why they don't on Earth," says Gilbert Levin of Arizona State University, who was a member of the NASA 1976 Viking Lander biology experiment team. "Their statement that Land D-life would consume each other is interesting, but I do not get their conclusion that indigenous life forms would win if Martian microbes were brought to Earth." When in balance, the microorganisms of the vaginal tract help to protect against HIV infections and also support the activity of the antiviral drug tenofovir, according to Richard Pyles at the University of Texas Medical Branch UTMB), Galveston, and his collaborators. Once the balance is disrupted, however, that drug loses its potency, they fınd while using a cell culture system that models the human vaginal tract. "It's the fırst time, to our knowledge, that someone has recreated an intact vaginal microbiome in a dish," he says. Details appear March
MINITOPIC

Pulsed Electric Fields Effective in Mice against Infected Burn Wounds
Microsecond-pulsed, high-voltage, nonthermal electric fields are effective in killing antibiotic-resistant strains of the bacterial pathogen Acinetobacter baumannii, which were applied to burns and caused localized infections in mice, according to Alexander Golberg of the Massachusetts General Hospital Center for Engineering in Medicine in Boston, Mass., and his collaborators. Treating the mice with two 40-pulse treatments five minutes apart, one group receiving 250 V/mm pulses and another receiving 500 V/mm pulses, reduced bacterial levels up to 10,000-fold, they report. Pulsed electric fields (PEFs) are used in the food industry to preserve food products and, more recently, PEFs are being used to treat solid tumors-acting by forming pores in membranes. Details Within the vaginal tract, Lactobacillus species produce hydrogen peroxide and lactic acid, both of which help to inhibit viral pathogens such as HIV, Pyles continues. However, when women develop bacterial vaginosis, an infection typically caused by Gardnerella vaginalis or other similar anaerobes, they will temporarily dominate and substantially reduce the numbers of Lactobacilli. This bacterial shift increases susceptibility to HIV and other sexually transmitted infections, he points out.
Some of these same conditions now can be studied in the cell culture system, which contains a mix of Lactobacillus species as well as vaginal epithelial cells that were collected from healthy women during routine examinations, according to Pyles. For example, the activity of a single dose of the anti-HIV drug tenofovir is substantially reduced when bacterial communities associated with bacterial vaginosis are also present within this system, they fınd. In contrast, tenofovir potently prevents HIV-1 replication when similar vaginal cultures are populated by lactobacillus-dominated healthy microbiomes. These fındings back up clinical observations that bacterial vaginosis raises the risk for HIV-1 transmission during intercourse.
"The incorporation of cells competent for HIV replication into the model is novel and adds signifıcantly to its utility to better understand how the vaginal microbiome influences susceptibility to HIV infection in women and HIV shedding in chronically infected women," says David H. Martin, chief of infectious diseases at Louisiana State University Health Sciences Center in New Orleans. The model also might be used to evaluate how variations in the vaginal microbiome affect conditions such as preterm delivery, and whether probiotics prevent such outcomes, he adds.
The human multilayer vaginal cell model provides a new means for studying how mixed bacterial communities might change how prescription medicines such as contraceptives or locally applied treatments affect the vaginal tract, according to Pyles. "A woman's particular microbiome may limit the activity," he says. "In the future, microbiomes could be enhanced by probiotics to enhance the effıcacy of drugs."
Carol Potera is a freelance writer in Great Falls, Mont.
RESEARCH ADVANCES
Solar Electricity Eyed To Drive Biofilms To Produce Butanol as Fuel David Holzman
Engineering microbes to capture carbon dioxide to produce organic chemicals, especially butanol for use as a fuel for cars and trucks, would be better than raising and then fermenting corn or other crops for that same end use, according to Derek Lovley of the University of Massachusetts, Amherst. He and his collaborators described projects aimed to produce such materials at several poster sessions during the 2014 ASM General Meeting in Boston last May.
Their general approach, called electrosynthesis, depends on electrical energy to drive microorganisms to form biofılms and to produce butanol or other organic chemicals. One such project focuses on Clostridium ljungdahlii, which grows to form a biofılm at the cathode of a redox cell. Electrici-
MINITOPIC
Bacteria Found in Surprising Places; Liver Filters Gut Microbiota
Researchers report finding bacteria in anatomical sites that were formerly considered sterile, including placentas and the bladder; meanwhile, biofilms in arterial plaque respond to stress signals, and the liver mops up bacteria that leak from the gut.
The human placenta provides a niche for a small but diverse mix of bacteria, resembling the microbiota of the mouth, according to ty-preferably captured from the sun-drives electrolysis at the anode, and electrons flow from there to the cathode, where the bacteria within the biofılm add these electrons to carbon dioxide, reducing it to acetyl coenzyme A (acetyl CoA).
Acetyl CoA is the "hub of metabolism" within many kinds of living cells, a critical building block for organic molecules that microorganisms might make, according to Lovley. He and his collaborators engineered C. ljungdahlii to produce high levels of butyrate from acetyl-CoA, and also deleted genes encoding enzymes that otherwise convert acetyl-CoA to acetate or that convert butyrate to other products. Production effıciency is roughly 70%, leaving enough energy to support cell growth and maintenance, he says. Next steps call for engineering a butanol-instead of a butyrate-producing strain and also one that is lactose inducible to control the timing of the production phase of the process.
Such microbial systems might someday offer advantages over agricultural biomass as a feedstock for fuels such as ethanol or butanol as well as other organic commodity chemicals, according to Lovley. In terms of land use, solar electricity is 100 times more effıcient than is plant-based photosynthesis, and thus would avoid removing farmland from food production, he says. For another, while about 70 gallons of water go into producing a gallon of fuel from biomass, not counting the water used earlier for irrigating crops, biofılm-based electrosynthesis spares such profligate water use. Nonagricultural fuel and organics production also avoids pollution problems such as nitrogen contamination of drinking water and the creation of oceanic "dead zones."
Although the C. ljungdahlii system is strictly laboratory stage, Lovley is collaborating with a group at LanzaTech, a biotechnology company in Chicago, Ill., to scale up this and closely related processes. The company, whose main business is to use fermentation processes to convert carbon dioxide or other gases being produced on an industrial scale into fuels, anticipates producing commercial fuel from Lovley-style, biofılm-based electrosynthesis as being at least a decade away, according to Robert Conrado, who is a senior development engineer at LanzaTech.
David Holzman is the Microbe Journal Highlights
Editor. At fırst glance, the archaeal species Sulfolobus acidocaldarius, which prefers to grow at 76°C and at a pH between 2 and 4, appears to swim about in liquid media much like motile bacteria such as Escherichia coli. However, the proteins responsible for motility in S. acidocaldarius more closely resemble those that are part of type IV pili assembly systems rather than flagella in bacteria, according to Albers. Indeed, those differences are so pronounced that she and her collaborators now refer to the archaeal flagella as the "archaella."
RESEARCH ADVANCES
Archaella Resemble Pili But
The genes encoding archaella proteins are well conserved and widely disseminated among motile archaea, according to Albers. In addition to its archaella, S. acidocaldarius has "several structures along the cell surface," including pili that are important for enabling such cells to adhere to one another and to other surfaces, she points out. Those pili also play a role during the exchange of DNA between cells of the same species, helping them to form aggregates.
Meanwhile, the archaella form much longer fılaments that extend outward from the cell surface. Like flagella of motile bacteria, the archaella of S. acidocaldarius can be tethered to solid surfaces, preventing the cells from swimming freely but showing that they continue to rotate when tied down in this fashion. Although such experiments entail doing light microscopy at 75°C, she refers to them as "reinventing the wheel," alluding to lower-temperature tethering experiments with motile bacteria from four decades ago by Howard Berg, now at Harvard University, and his collaborators. The rotary motor for the archaella of S. acidocaldarius is "very simple" and consists of seven different proteins, several of them in multiple copies, which is in contrast to the motor driving bacterial flagella, consisting of about 50 different proteins, Albers notes. Of the seven archaella proteins, Fla H appears to be a clock protein that is regulated by being phosphorylated and then dephosphorylated. However, it appears not to have a circadian function but to interact with the Fla X protein to determine the overall length of the fılament as each archaellum is being assembled and before it can begin to rotate, she says. Meanwhile, Fla F appears to serve as the anchor protein in the envelope of the cell and to act as the stator part of the motor. "We are still mostly speculating about the mechanism," she says.
Jeffrey L. Fox is the Microbe Current Topics and Features Editor.
NEW IN ASM JOURNALS
By Targeting Host Immune Response Instead of Virus, Investigators Identify Potential Anti-H7N9 Therapeutics
The seriousness of disease often results from the strength of immune response, rather than with the virus itself. Turning down that response, rather than attacking the virus, might be a better way to reduce that severity, says Juliet Morrison of the University of Washington (UW), Seattle. She and her collaborators have now taken the fırst step in doing just that for the H7N9 influenza. "We found that viruses that cause severe illness, like H7N9, and the infamous 1918 virus, trigger gene expression signatures that are different from those seen in milder infections," says coauthor and UW laboratory head Michael Katze. The investigators searched databases containing gene expression profıles of cultured human cells that had been treated with different drugs in order to fınd those cells with gene expression profıles that were the reverse of those induced by the H7N9 flu virus. Drugs that generated such could potentially dampen the harmful host response, Morrison says.
MINITOPIC
Recent Findings Linking Gut Microbiota Diversity to Disease and Diet
Keeping current with research involving the microbiota of the gut proves a major challenge. Additional recent developments include:
• Malnutrition during childhood upsets the gut microbiota, leaving it so "immature" that food-based interventions prove only partly corrective, according to 
NEW IN ASM JOURNALS
Novel Intravaginal Ring Shows Promise for HIV Prevention
A novel intravaginal ring for prevention of HIV transmission, implanted with antiretroviral drug tablets, demonstrated sustained, controlled drug release and safety over 28 days. The ring, tested in pig-tailed macaque monkeys, is engineered to be inexpensive for use in developing countries, says corresponding author Marc Baum of the Oak Crest Institute of Science, Pasadena, Calif. One of the two drug combinations tested in the ring is the only product approved by the U.S. Food and Drug Administration (FDA) for HIV prophylaxis. The ring's topical drug delivery has critical advantages over oral therapy: "Issues such as adherence to a regular dosing schedule are significantly reduced," says Baum. Additionally, concentrations in vaginal tissues, the key compartment for preventing sexual HIV transmission, lack the troughs encountered with oral medications. Further, "systemic levels are so low as to usually be undetectable in topical delivery," says Baum. "That means that side effects are dramatically reduced, or eliminated entirely." Immune defenses and associated inflammation were not triggered. Baum notes that the pig-tailed macaque model is an ideal surrogate for humans. "The model has similarities with the human menstrual cycle, vaginal architecture, and vaginal microbiome, and the ability to conduct effıcacy studies with simian-human immunodefıciency virus," he says.
